Literature DB >> 15468823

Fabrication of synthetic apatites by solid-state reactions.

F Fazan1, K B N Shahida.   

Abstract

The paper presents a method of producing synthetic Hydroxyapatite (HA) Ca10(PO4)6(OH)2 and other apatites for biological use by solid-state reaction. The solid-state reaction involves mix-grinding dry powders of beta-tricalcium phosphate powder (TCP) and either calcium hydroxide (Ca(OH)2) or calcium carbonate (CaCO3) or combination thereof, from pure commercial chemicals or derived from natural limestone or from seashells, of total calcium/phosphorus molar ratio between 1.5 to 2.0, to particle size of less than 10 microns, and firing the resultant powder to temperature between 600 degrees C - 1250 degrees C in atmosphere or in controlled atmospheric condition. The resultant apatites formed were characterised using XRD, SEM-EDX and FTIR. The presented reaction process was found to be much simpler compared to conventional methods of producing synthetic apatites since it involves only dry mix-grinding of the reactants before firing at high temperatures based on the required levels of purity. It can also produce synthetic apatites with good reproducibility in a shorter time. Thus the presented method has a great industrial value.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15468823

Source DB:  PubMed          Journal:  Med J Malaysia        ISSN: 0300-5283


  3 in total

1.  The thermal stability of hydroxyapatite in biphasic calcium phosphate ceramics.

Authors:  R W N Nilen; P W Richter
Journal:  J Mater Sci Mater Med       Date:  2007-09-25       Impact factor: 3.896

2.  Cell responses to two kinds of nanohydroxyapatite with different sizes and crystallinities.

Authors:  Xiaochen Liu; Minzhi Zhao; Jingxiong Lu; Jian Ma; Jie Wei; Shicheng Wei
Journal:  Int J Nanomedicine       Date:  2012-03-07

3.  The induction of bone formation by smart biphasic hydroxyapatite tricalcium phosphate biomimetic matrices in the non-human primate Papio ursinus.

Authors:  U Ripamonti; P W Richter; R W N Nilen; L Renton
Journal:  J Cell Mol Med       Date:  2008-03-19       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.